We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · June 22, 2022

Long-Term Low-Dose Acetylsalicylic Use Protects Against Vascular Dementia and AD in Patients With Coronary Heart Disease

Alzheimer's Research &Therapy

 

Additional Info

Alzheimer's Research &Therapy
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer's disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
Alzheimers Res Ther 2022 May 28;14(1)75, TNM Nguyen, LJ Chen, K Trares, H Stocker, B Holleczek, K Beyreuther, H Brenner, B Schöttker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading